The Effect of Cardiovascular Morbidity on Clinical Responsiveness to Anticholinergics in Postmenopausal Women With Urge Urinary Incontinence

Basit Öğe Kaydı
dc.contributor.authorSelvi, Ismail
dc.contributor.authorBaydilli, Numan
dc.contributor.authorArik, Ali Ihsan
dc.contributor.authorBasar, Halil
dc.date.accessioned2024-09-29T16:00:53Z
dc.date.available2024-09-29T16:00:53Z
dc.date.issued2021
dc.departmentKarabük Üniversitesien_US
dc.description.abstractOBJECTIVE To evaluate whether there is an association between severity of cardiovascular morbidity and urge urinary incontinence (UUI), and to assess the clinical responses of postmenopausal female patients in different cardiovascular risk groups to anticholinergics. METHODS A total of 220 postmenopausal female patients aged 43-70 years old with overactive bladder with UUI between December 2019 and July 2020 were included. They were divided into 3 groups according to the Framingham risk score that calculates the 10-year risk of cardiovascular disease development: low-risk (n: 90, 40.9%), intermediate-risk (n: 47, 21.3%), and high-risk (n: 83, 37.8%).Their demographic and clinical data were recorded. The intensity of UUI and its effect on quality of life (QoL) were evaluated at admission, 8th week and 16th week of anticholinergic therapy. RESULTS At admission attendance, BMI, smoking rate, presence of hypertension and diabetes mellitus, total cholesterol level and severity of UUI were higher in the high-risk group, whereas HDL level was lower and the effect of UUI on QoL was worse (P<.001). At the 16-week follow-up the improvement of UUI severity and QoL was significantly more pronounced in the low-risk and intermediate-risk groups (P<.001).The highest daily-dryness rates were observed in the low-risk group (65.6%), while the highest rates for refractory overactive bladder (OAB) were seen in the high-risk group (19.3%). CONCLUSION Our findings show that more severe UUI and more impaired QoL is observed in high-risk patients for cardiovascular morbidity. Individualized treatment may be important in the high-risk group since they may benefit less from anticholinergics and refractory OAB can be more common. (C) 2020 Elsevier Inc.en_US
dc.identifier.doi10.1016/j.urology.2020.10.033
dc.identifier.endpage103en_US
dc.identifier.issn0090-4295
dc.identifier.issn1527-9995
dc.identifier.pmid33159919en_US
dc.identifier.startpage96en_US
dc.identifier.urihttps://doi.org/10.1016/j.urology.2020.10.033
dc.identifier.urihttps://hdl.handle.net/20.500.14619/5419
dc.identifier.volume147en_US
dc.identifier.wosWOS:000611143200021en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevier Science Incen_US
dc.relation.ispartofUrologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectOveractive Bladderen_US
dc.subjectMetabolic Syndromeen_US
dc.subjectSymptomsen_US
dc.subjectLinken_US
dc.titleThe Effect of Cardiovascular Morbidity on Clinical Responsiveness to Anticholinergics in Postmenopausal Women With Urge Urinary Incontinenceen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu